Standout Papers

The anti-PD-L1/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel in first-line treatment of metastatic triple-negative breast cancer: a multicenter phase II trial... 2024 202637
  1. The anti-PD-L1/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel in first-line treatment of metastatic triple-negative breast cancer: a multicenter phase II trial (2024)
    Qiao Li, Qingyuan Zhang et al. Nature Communications

Immediate Impact

2 from Science/Nature 66 standout
Sub-graph 1 of 23

Citing Papers

Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
2024 Standout
Autophagy-driven regulation of cisplatin response in human cancers: Exploring molecular and cell death dynamics
2024 Standout
1 intermediate paper

Works of Feng Ye being referenced

CircPVT1 promotes ER‐positive breast tumorigenesis and drug resistance by targeting ESR1 and MAVS
2023
Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging and Multidetector-Row Computed Tomography for the Diagnosis of Hepatocellular Carcinoma
2015

Author Peers

Author Last Decade Papers Cites
Feng Ye 316 216 128 450 414 54 1.0k
Lidia Puzzo 222 148 127 501 253 72 1.3k
Kaiyu Sun 434 247 82 425 387 37 1.1k
Hye Won Lee 184 106 134 458 383 77 923
Jean-Philippe Dalès 406 156 54 530 393 46 1.0k
Xiaobin Gu 730 357 136 328 327 51 1.3k
Monica Leutner 273 172 106 167 218 35 915
Eric Q. Konnick 318 339 117 303 359 42 926
Feng Luo 455 163 151 266 156 57 894
Jacob R. Izbicki 567 352 68 281 253 45 1.3k
Marc Matrana 509 523 88 378 244 88 1.1k

All Works

Loading papers...

Rankless by CCL
2026